Edition:
United Kingdom

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

1.44USD
17 Jul 2019
Change (% chg)

$-0.01 (-0.69%)
Prev Close
$1.45
Open
$1.43
Day's High
$1.57
Day's Low
$1.37
Volume
290,365
Avg. Vol
126,554
52-wk High
$4.86
52-wk Low
$1.28

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $387.58
Shares Outstanding(Mil.): 36.22
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -2.29 -- --
ROI: -50.00 8.96 14.49
ROE: -52.94 10.09 15.79

Earnings vs. Estimates